Skip to content
  • Home
  • Board of Directors
  • 16th Symposium
    • Scientific Program
    • Posters Presentation
    • Registration fees
  • Knowledge Center
    • Guidelines
      • Clinical
      • Legal and Regulatory
    • Articles
      • Bone marrow cell therapy
      • Colony-stimulating factors therapy
      • Myoblast therapy
      • Preclinical research
      • Regulatory texts
      • Reviews
    • Books
    • Research
      • By clinical setting
  • Tecam
    • Past Symposia
    • TECAM Faculty
    • Photo Gallery
  • Upcoming Events
    • 2014 Events
    • 2013 Events
    • 2012 Events
    • 2011 Events
  • Links
  • Contact
person_outline
search
share email print
adminAuthor website
  • Guidelines, Legal and Regulatory, Official Journal of the European Union
  • 18 February, 2005

COMMISSION DIRECTIVE 2005/28/EC of 8 April 2005

  • dir_2005_28_en.pdf
  • Journal Official Journal of the European Union
  • Year 2005

Laying down principles and detailed guidelines for good clinical practice as regards investigational medicinal products for human use, as well as the requirements for authorization of the manufacturing or importation of such products

Cardiovascularcelltherapy
carlos3
ter
complutense
ifm
gregorio-maranon
igm
logo
logo

Download APP


Facebook Posts

This message is only visible to admins.

Problem displaying Facebook posts.
Click to show error

Error: An access token is required to request this resource.
Type: OAuthException
Solution: See here for how to solve this error
Follow us on: facebook twitter
more_vert
© 2015 Cadiovascular Cell Therapy Developed by Trama Solutions